French lab group Biogroup is hoping to test the transportation of urgent samples in France by drone by the end of the year, subject to the approval of the French Civil Aviation Authority.
A pioneering blood test which helps clinicians diagnose bipolar disorder will come to market shortly. HBI catches up with Alexandra Prieux, CEO at France-based ALCEDIAG, which should be first to market with the first of what could be a series of tests.
"This is the strongest M&A market I can remember," Hedley Goldberg, managing director at Rothschild & Co told hundreds of attendees at HBI 2021 as he talked about the IPO landscape and how post-COVID M&A is shaping up.
Increasing demand and rising costs are putting pressure on LatAm’s healthcare system. A regional session at HBI 2021 heard that out-of-pocket payments are on the increase, especially in Mexico.
Analysts and strategists in the diagnostics sector have been racking their heads over what business will look like in a post-Covid world. There is a lot of uncertainty over how much of the current Covid testing volume will remain, and how much growth will be seen in B2C demand for other disease testing.
Potential winners of Germany's upcoming elections are pledging to abolish private medical insurance (PKV). The move could spell disaster for the whole healthcare sector: it accounts for 37% of all expenditure.
The direct-to-consumer or B2C diagnostics sector began well before Covid. Over the past decade, increasing numbers of people have used at-home testing kits to screen for a variety of diseases (cancers, cardiac diseases and STIs), as well as to evaluate genetic susceptibility and find out about their ancestry.
The consolidation of The Netherlands' non-profit outpatient diagnostics sector by for-profit groups is expected to pick up in the coming months after a delay due to Covid, a partner at Deloitte tells HBI.
HBI hears rumour that pan-European laboratory and imaging group Unilabs could sell soon. We explore how its private equity owner Apax could make a much-anticipated exit.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
